Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal

Showing results (151-160 of 276) with videos related to

Pageof 28
Sort By:
Iscience|January 28, 2019
Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCsYasamin Dabiri, Rodrigo A Gama-Brambila, Katerina Taškova, et al.
British Journal of Cancer|February 18, 2020
T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cellsKarol Granados, Laura Hüser, Aniello Federico, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 25, 2021
S1-Guideline Cutaneous Angiosarcomas - Update 2021Thomas Vogt, Cornelia S L Müller, Patrick Melchior, et al.
Plos One|May 26, 2018
Willingness to pay for a cure of low-risk melanoma patients in GermanyMatthias Augustin, Christine Blome, Andrea Forschner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 11, 2022
Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
International Journal of Molecular Sciences|September 28, 2023
Flagellin-Induced Immune Response in Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesGoekhan Yuecel, Xiaobo Zhou, Linda Terkatz, et al.
Cancers|November 26, 2022
Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in MelanomaNadine L Ammann, Yasmin F Schwietzer, Christian Mess, et al.
International Journal of Cancer|May 28, 2019
Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic targetElias Orouji, Aniello Federico, Lionel Larribère, et al.
Cancer Research|November 2, 2017
CCR5<sup>+</sup> Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma LesionsCarolin Blattner, Viktor Fleming, Rebekka Weber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 11, 2021
Thomas Vogt, Cornelia S L Müller, Patrick Melchior, et al.
Pageof 28

Showing results (151-160 of 276) with videos related to

Sort By:
Pageof 28
Iscience|January 28, 2019
Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCsYasamin Dabiri, Rodrigo A Gama-Brambila, Katerina Taškova, et al.
British Journal of Cancer|February 18, 2020
T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cellsKarol Granados, Laura Hüser, Aniello Federico, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 25, 2021
S1-Guideline Cutaneous Angiosarcomas - Update 2021Thomas Vogt, Cornelia S L Müller, Patrick Melchior, et al.
Plos One|May 26, 2018
Willingness to pay for a cure of low-risk melanoma patients in GermanyMatthias Augustin, Christine Blome, Andrea Forschner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 11, 2022
Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
International Journal of Molecular Sciences|September 28, 2023
Flagellin-Induced Immune Response in Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesGoekhan Yuecel, Xiaobo Zhou, Linda Terkatz, et al.
Cancers|November 26, 2022
Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in MelanomaNadine L Ammann, Yasmin F Schwietzer, Christian Mess, et al.
International Journal of Cancer|May 28, 2019
Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic targetElias Orouji, Aniello Federico, Lionel Larribère, et al.
Cancer Research|November 2, 2017
CCR5<sup>+</sup> Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma LesionsCarolin Blattner, Viktor Fleming, Rebekka Weber, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 11, 2021
Thomas Vogt, Cornelia S L Müller, Patrick Melchior, et al.
Pageof 28